Related Experiment Video
Updated: Oct 28, 2025

08:06
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
32.0K
Neuro4PD: An Initial Neurorobotics Model of Parkinson's Disease
Jhielson M Pimentel1, Renan C Moioli2, Mariana F P de Araujo3
1Edinburgh Centre for Robotics, Heriot-Watt University, Edinburgh, United Kingdom.
Frontiers in Neurorobotics
|July 19, 2021
Summary
Researchers developed a novel neurorobotics model of Parkinson's Disease (PD), embedding a computational PD model into a humanoid robot. This model simulates motor disturbances in PD, paving the way for new therapies.
Area of Science:
- Neurorobotics
- Computational Neuroscience
- Robotics Engineering
Background:
- Parkinson's Disease (PD) significantly impacts human motor control.
- PD prevalence is projected to double in 15 years, with no current cure.
- Existing models often lack real-world robotic implementation.
Purpose of the Study:
- To create and validate a neurorobotics model of Parkinson's Disease.
- To embed a computational PD model into a humanoid robot for the first time.
- To explore PD dynamics and motor disturbances in a physical system.
Main Methods:
- Development of a novel neurorobotics system.
- Integration of a well-established computational model of Parkinson's Disease into a humanoid robot.
- Testing the robot's ability to perform a behavioral task under simulated healthy and parkinsonian conditions.
Main Results:
- The embedded model successfully simulated motor disturbances characteristic of Parkinson's Disease.
- The neurorobotics model performed a behavioral task with varying levels of motor impairment.
- Demonstrated the feasibility of using a physical robot to study PD.
Conclusions:
- This neurorobotics model represents a significant advancement in Parkinson's Disease research.
- The model can serve as a platform for testing novel therapeutic strategies.
- It offers a potential method to reduce and replace animal models in PD research.
Related Concept Videos
Parkinson's Disease: Overview
991
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
991
Parkinson's Disease: Treatment
569
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
569
Neural Regulation
40.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.6K
EPS and iPS Cells in Disease Research
3.0K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.0K

